Erika Bondareva

Erika Bondareva

Auto-generated profile, based on publicly available information

Erika Bondareva

University of Cambridge, Cambridge, United Kingdom

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2022 in Journal of Medical Internet Research
Verified
Journal Article
Open access
TDTing Dang
Ting Dang
JHJing Han
Jing Han
TXTong Xia
Tong Xia
DSDimitris Spathis
Dimitris Spathis
EBErika Bondareva
Erika Bondareva
CMCecilia Mascolo
Cecilia Mascolo
Background: Recent work has shown the potential of using audio data (eg, cough, breathing, and voice) in the screening for COVID-19. However, these approaches only focus on one-off detection and detect the infection, given the current audio sample, but do not monitor disease progression in COVID-19. Limited exploration has been put forward to continuously monitor COVID-19 progression, especially recovery, through longitudinal audio data. Tracking disease progression characteristics and patterns of recovery could bring insights and lead to more timely treatment or treatment adjustment, as well as better resource management in health care systems. Objective: The primary objective of this study is to explore the potential of longitudinal audio samples over time for COVID-19 progression prediction and, especially, recovery trend prediction using sequential deep learning techniques. Methods: Crowdsourced respiratory audio data, including breathing, cough, and voice samples, from 212 individuals over 5-385 days were analyzed, alongside their self-reported COVID-19 test results. We developed and validated a deep learning–enabled tracking tool using gated recurrent units (GRUs) to detect COVID-19 progression by exploring the audio dynamics of the individuals’ historical audio biomarkers. The investigation comprised 2 parts: (1) COVID-19 detection in terms of positive and negative (healthy) tests using sequential audio signals, which was primarily assessed in terms of the area under the receiver operating characteristic curve (AUROC), sensitivity, and specificity, with 95% CIs, and (2) longitudinal disease progression prediction over time in terms of probability of positive tests, which was evaluated using the correlation between the predicted probability trajectory and self-reported labels. Results: We first explored the benefits of capturing longitudinal dynamics of audio biomarkers for COVID-19 detection. The strong performance, yielding an AUROC of 0.79, a sensitivity of 0.75, and a specificity of 0.71 supported the effectiveness of the approach compared to methods that do not leverage longitudinal dynamics. We further examined the predicted disease progression trajectory, which displayed high consistency with longitudinal test results with a correlation of 0.75 in the test cohort and 0.86 in a subset of the test cohort with 12 (57.1%) of 21 COVID-19–positive participants who reported disease recovery. Our findings suggest that monitoring COVID-19 evolution via longitudinal audio data has potential in the tracking of individuals’ disease progression and recovery. Conclusions: An audio-based COVID-19 progression monitoring system was developed using deep learning techniques, with strong performance showing high consistency between the predicted trajectory and the test results over time, especially for recovery trend predictions. This has good potential in the postpeak and postpandemic era that can help guide medical treatment and optimize hospital resource allocations. The changes in longitudinal audio samples, referred to as audio dynamics, are associated with COVID-19 progression; thus, modeling the audio dynamics can potentially capture the underlying disease progression process and further aid COVID-19 progression prediction. This framework provides a flexible, affordable, and timely tool for COVID-19 tracking, and more importantly, it also provides a proof of concept of how telemonitoring could be applicable to respiratory diseases monitoring, in general.

4 August 2023
Verified
Conference Paper
Open access
TDTing Dang
Ting Dang
JHJing Han
Jing Han
TXTong Xia
Tong Xia
EBErika Bondareva
Erika Bondareva
CSChloë Siegele-Brown
Chloë Siegele-Brown
CMCecilia Mascolo
Cecilia Mascolo
Time series forecasting, as one of the fundamental machine learning areas, has attracted tremendous attentions over recent years. The solutions have evolved from statistical machine learning (ML) methods to deep learning techniques. One emerging sub-field of time series forecasting is individual disease progression forecasting, e.g., predicting individuals' disease development over a few days (e.g., deteriorating trends, recovery speed) based on few past observations. Despite the promises in the existing ML techniques, a variety of unique challenges emerge for disease progression forecasting, such as irregularly-sampled time series, data sparsity, and individual heterogeneity in disease progression. To tackle these challenges, we propose novel Conditional Neural Ordinary Differential Equations Processes (CNDPs), and validate it in a COVID-19 disease progression forecasting task using audio data. CNDPs allow for irregularly-sampled time series modelling, enable accurate forecasting with sparse past observations, and achieve individual-level progression forecasting. CNDPs show strong performance with an Unweighted Average Recall (UAR) of 78.1%, outperforming a variety of commonly used Recurrent Neural Networks based models. With the proposed label-enhancing mechanism (i.e., including the initial health status as input) and the customised individual-level loss, CNDPs further boost the performance reaching a UAR of 93.6%. Additional analysis also reveals the model's capability in tracking individual-specific recovery trend, implying the potential usage of the model for remote disease progression monitoring. In general, CNDPs pave new pathways for time series forecasting, and provide considerable advantages for disease progression monitoring.

9 May 2023 in Journal of Medical Internet Research
Verified
Journal Article
Open access
JHJing Han
Jing Han
MMMarco Montagna
Marco Montagna
AGAndreas Grammenos
Andreas Grammenos
TXTong Xia
Tong Xia
EBErika Bondareva
Erika Bondareva
CMCecilia Mascolo
Cecilia Mascolo
Background: To date, performance comparisons between men and machines have been carried out in many health domains. Yet machine learning (ML) models and human performance comparisons in audio-based respiratory diagnosis remain largely unexplored. Objective: The primary objective of this study was to compare human clinicians and an ML model in predicting COVID-19 from respiratory sound recordings. Methods: In this study, we compared human clinicians and an ML model in predicting COVID-19 from respiratory sound recordings. Prediction performance on 24 audio samples (12 tested positive) made by 36 clinicians with experience in treating COVID-19 or other respiratory illnesses was compared with predictions made by an ML model trained on 1162 samples. Each sample consisted of voice, cough, and breathing sound recordings from 1 subject, and the length of each sample was around 20 seconds. We also investigated whether combining the predictions of the model and human experts could further enhance the performance in terms of both accuracy and confidence. Results: The ML model outperformed the clinicians, yielding a sensitivity of 0.75 and a specificity of 0.83, whereas the best performance achieved by the clinicians was 0.67 in terms of sensitivity and 0.75 in terms of specificity. Integrating the clinicians’ and the model’s predictions, however, could enhance performance further, achieving a sensitivity of 0.83 and a specificity of 0.92. Conclusions: Our findings suggest that the clinicians and the ML model could make better clinical decisions via a cooperative approach and achieve higher confidence in audio-based respiratory diagnosis.

4 June 2023
Verified
Conference Paper
Open access
JSJake Stuchbury-Wass
Jake Stuchbury-Wass
EBErika Bondareva
Erika Bondareva
KBKayla-Jade Butkow
Kayla-Jade Butkow
SŠSanja Šćepanović
Sanja Šćepanović
ZRZoran Radivojevic
Zoran Radivojevic
CMCecilia Mascolo
Cecilia Mascolo
Abdominal sounds (ABS) have been traditionally used for assessing gastrointestinal (GI) disorders. However, the assessment requires a trained medical professional to perform multiple abdominal auscultation sessions, which is resource-intense and may fail to provide an accurate picture of patients’ continuous GI wellbeing. This has generated a technological interest in developing wearables for continuous capture of ABS, which enables a fuller picture of patient’s GI status to be obtained at reduced cost. This paper seeks to evaluate the feasibility of extracting heart rate (HR) from such ABS monitoring devices. The collection of HR directly from these devices would enable gathering vital signs alongside GI data without the need for additional wearable devices, providing further cost benefits and improving general usability. We utilised a dataset containing 104 hours of ABS audio, collected from the abdomen using an e-stethoscope, and electrocardiogram as ground truth. Our evaluation shows for the first time that we can successfully extract HR from audio collected from a wearable on the abdomen. As heart sounds collected from the abdomen suffer from significant noise from GI and respiratory tracts, we leverage wavelet denoising for improved heart beat detection. The mean absolute error of the algorithm for average HR is 3.4BPM with mean directional error of -1.2BPM over the whole dataset. A comparison to photoplethysmography-based wearable HR sensors shows that our approach exhibits comparable accuracy to consumer wrist-worn wearables for average and instantaneous heart rate.

4 February 2022 in JMIR Preprints
Verified
Preprint
Open access
TDTing Dang
Ting Dang
JHJing Han
Jing Han
TXTong Xia
Tong Xia
DSDimitris Spathis
Dimitris Spathis
EBErika Bondareva
Erika Bondareva
CMCecilia Mascolo
Cecilia Mascolo
BACKGROUND Recent work has shown the potential of using audio data (eg, cough, breathing, and voice) in the screening for COVID-19. However, these approaches only focus on one-off detection and detect the infection, given the current audio sample, but do not monitor disease progression in COVID-19. Limited exploration has been put forward to continuously monitor COVID-19 progression, especially recovery, through longitudinal audio data. Tracking disease progression characteristics and patterns of recovery could bring insights and lead to more timely treatment or treatment adjustment, as well as better resource management in health care systems. OBJECTIVE The primary objective of this study is to explore the potential of longitudinal audio samples over time for COVID-19 progression prediction and, especially, recovery trend prediction using sequential deep learning techniques. METHODS Crowdsourced respiratory audio data, including breathing, cough, and voice samples, from 212 individuals over 5-385 days were analyzed, alongside their self-reported COVID-19 test results. We developed and validated a deep learning–enabled tracking tool using gated recurrent units (GRUs) to detect COVID-19 progression by exploring the audio dynamics of the individuals’ historical audio biomarkers. The investigation comprised 2 parts: (1) COVID-19 detection in terms of positive and negative (healthy) tests using sequential audio signals, which was primarily assessed in terms of the area under the receiver operating characteristic curve (AUROC), sensitivity, and specificity, with 95% CIs, and (2) longitudinal disease progression prediction over time in terms of probability of positive tests, which was evaluated using the correlation between the predicted probability trajectory and self-reported labels. RESULTS We first explored the benefits of capturing longitudinal dynamics of audio biomarkers for COVID-19 detection. The strong performance, yielding an AUROC of 0.79, a sensitivity of 0.75, and a specificity of 0.71 supported the effectiveness of the approach compared to methods that do not leverage longitudinal dynamics. We further examined the predicted disease progression trajectory, which displayed high consistency with longitudinal test results with a correlation of 0.75 in the test cohort and 0.86 in a subset of the test cohort with 12 (57.1%) of 21 COVID-19–positive participants who reported disease recovery. Our findings suggest that monitoring COVID-19 evolution via longitudinal audio data has potential in the tracking of individuals’ disease progression and recovery. CONCLUSIONS An audio-based COVID-19 progression monitoring system was developed using deep learning techniques, with strong performance showing high consistency between the predicted trajectory and the test results over time, especially for recovery trend predictions. This has good potential in the postpeak and postpandemic era that can help guide medical treatment and optimize hospital resource allocations. The changes in longitudinal audio samples, referred to as audio dynamics, are associated with COVID-19 progression; thus, modeling the audio dynamics can potentially capture the underlying disease progression process and further aid COVID-19 progression prediction. This framework provides a flexible, affordable, and timely tool for COVID-19 tracking, and more importantly, it also provides a proof of concept of how telemonitoring could be applicable to respiratory diseases monitoring, in general.